MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

What Does Sarepta Therapeutics' Director Share Sale Signal to Investors

1 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Does Director Mitchell Tyson's Substantial Share Sale Mean for Photronics Investors

4 weeks ago

What Does Director Edman's Recent Sale Mean for TTMI Investors

1 months ago

What Does a Director's Sale of HURN Shares Really Mean

1 months ago

What Does a CAO's Share Sale and Resignation Signal for Enhabit (EHAB) Investors

1 months ago

Senseonics Shares Sink Friday: What's Driving The Move?

Senseonics Holdings shares fell sharply Friday morning after the company priced an $80 million underwritten public offering late Thursday. The capital raise introduces immediate dilution for existing ...

SENS

Stock News•3 days ago

Is DoubleVerify a Buy? One Fund Just Opened a $3.5 Million Position

DoubleVerify attracted a new $3.5M investment from an institutional fund, signaling potential confidence in the digital advertising software firm's measurement and analytics tools. This capital inject...

Stock News•4 days ago

President CEO Sells HMN 7,500 Shares for $346,000

HMN President and CEO sold 7,500 shares for $346,000, according to a recent SEC filing. The company provides insurance and retirement products to the education sector.

HMN

Stock News•4 days ago

Sarepta Therapeutics (SRPT) Reports Next Week: Wall Street Expects Earnings Growth

Sarepta Therapeutics (SRPT) is expected to report earnings growth in its upcoming quarterly results next week. Analysts suggest the company possesses the necessary catalysts to potentially outperform ...

SRPT